GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zhejiang Ausun Pharmaceutical Co Ltd (SHSE:603229) » Definitions » Gross Margin %
中文

Zhejiang Ausun Pharmaceutical Co (SHSE:603229) Gross Margin %

: 56.92% (As of Sep. 2023)
View and export this data going back to 2017. Start your Free Trial

Gross Margin % is calculated as gross profit divided by its revenue. Zhejiang Ausun Pharmaceutical Co's Gross Profit for the three months ended in Sep. 2023 was ¥115.5 Mil. Zhejiang Ausun Pharmaceutical Co's Revenue for the three months ended in Sep. 2023 was ¥202.9 Mil. Therefore, Zhejiang Ausun Pharmaceutical Co's Gross Margin % for the quarter that ended in Sep. 2023 was 56.92%.


The historical rank and industry rank for Zhejiang Ausun Pharmaceutical Co's Gross Margin % or its related term are showing as below:

SHSE:603229' s Gross Margin % Range Over the Past 10 Years
Min: 44.65   Med: 52.88   Max: 60.4
Current: 56.9


During the past 11 years, the highest Gross Margin % of Zhejiang Ausun Pharmaceutical Co was 60.40%. The lowest was 44.65%. And the median was 52.88%.

SHSE:603229's Gross Margin % is ranked worse than
52.65% of 735 companies
in the Biotechnology industry
Industry Median: 59.86 vs SHSE:603229: 56.90

Zhejiang Ausun Pharmaceutical Co had a gross margin of 56.92% for the quarter that ended in Sep. 2023 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Zhejiang Ausun Pharmaceutical Co was -0.30% per year.


Zhejiang Ausun Pharmaceutical Co Gross Margin % Historical Data

The historical data trend for Zhejiang Ausun Pharmaceutical Co's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Ausun Pharmaceutical Co Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 44.65 51.78 56.43 54.79 51.50

Zhejiang Ausun Pharmaceutical Co Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 49.76 54.13 58.89 56.87 56.92

Competitive Comparison

For the Biotechnology subindustry, Zhejiang Ausun Pharmaceutical Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhejiang Ausun Pharmaceutical Co Gross Margin % Distribution

For the Biotechnology industry and Healthcare sector, Zhejiang Ausun Pharmaceutical Co's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Zhejiang Ausun Pharmaceutical Co's Gross Margin % falls into.



Zhejiang Ausun Pharmaceutical Co Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Zhejiang Ausun Pharmaceutical Co's Gross Margin for the fiscal year that ended in Dec. 2022 is calculated as

Gross Margin % (A: Dec. 2022 )=Gross Profit (A: Dec. 2022 ) / Revenue (A: Dec. 2022 )
=393.8 / 764.547
=(Revenue - Cost of Goods Sold) / Revenue
=(764.547 - 370.794) / 764.547
=51.50 %

Zhejiang Ausun Pharmaceutical Co's Gross Margin for the quarter that ended in Sep. 2023 is calculated as


Gross Margin % (Q: Sep. 2023 )=Gross Profit (Q: Sep. 2023 ) / Revenue (Q: Sep. 2023 )
=115.5 / 202.946
=(Revenue - Cost of Goods Sold) / Revenue
=(202.946 - 87.436) / 202.946
=56.92 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Zhejiang Ausun Pharmaceutical Co  (SHSE:603229) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Zhejiang Ausun Pharmaceutical Co had a gross margin of 56.92% for the quarter that ended in Sep. 2023 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Zhejiang Ausun Pharmaceutical Co Gross Margin % Related Terms

Thank you for viewing the detailed overview of Zhejiang Ausun Pharmaceutical Co's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Ausun Pharmaceutical Co (SHSE:603229) Business Description

Traded in Other Exchanges
N/A
Address
No.5, Donghai 4th Avenue, chemical raw materials base Linhai Park East, Zhejiang Province, Taizhou, CHN, 317016
Zhejiang Ausun Pharmaceutical Co Ltd is mainly engaged in the research and development, production and sales of specialty APIs and pharmaceutical intermediates, as well as providing customized production and research for customers. Its products portfolio includes Prostaglandins and their intermediates, Raw material medicine, Fluorine series and Develop products.

Zhejiang Ausun Pharmaceutical Co (SHSE:603229) Headlines

No Headlines